Related Experiment Video
Updated: Jun 26, 2026

Murine Intrapulmonary Tracheal Transplantation: A Model for Investigating Obliterative Airway Disease After Lung Transplantation
Published on: November 10, 2023
Infections relevant to lung transplantation
Kaspar F Remund1, Matthew Best, Jim J Egan
1Advanced Lung Disease and Lung Transplant Programme, Mater Misericordiae University Hospital, University College Dublin, Dublin, Ireland.
Lung transplant recipients face a high risk of allograft infection due to environmental exposure and immunosuppression. While prophylactic antibiotics help, varied prevention strategies leave efficacy questions unanswered.
Area of Science:
- Medicine
- Immunology
- Infectious Diseases
Background:
- Pulmonary allograft infection significantly impacts lung transplant outcomes and presents diagnostic challenges.
- The transplanted lung is susceptible to infection due to environmental microbial exposure, immunosuppression, and impaired clearance post-denervation.
- Common infecting agents include Pseudomonas aeruginosa, cytomegalovirus, respiratory viruses, and Aspergillus species.
Purpose of the Study:
- To review the challenges and spectrum of allograft infections following lung transplantation.
- To discuss the role of prophylactic antimicrobial strategies in reducing infectious complications.
- To highlight the heterogeneity in preventive strategies across transplant centers and remaining unanswered questions.
Main Methods:
- Literature review of studies on post-lung transplantation infections.
- Analysis of common microbial pathogens and risk factors for allograft infection.
- Evaluation of the impact of prophylactic antimicrobial treatments.
Main Results:
- Allograft infection is a major complication in lung transplantation, influenced by multiple factors.
- Prophylactic antimicrobial regimens have shown a reduced incidence of infections.
- Significant heterogeneity exists in preventive strategies among transplant centers, with unresolved efficacy concerns.
Conclusions:
- Infections pose a significant threat to lung allograft survival and patient outcomes.
- Standardized and evidence-based preventive strategies are needed to optimize infectious complication management.
- Further research is required to address the efficacy of various prophylactic measures in lung transplantation.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction
Microbiota of the Respiratory Tract
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Kidney Transplant III: Nursing Management

